Definitive Contract 75N93020C00022
Award Date
7/1/20
Potential Completion Date
8/31/22
Potential Value
$573K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Ampersand Biosciences LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
UPPER ST REG, NY 12945, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This $596,519 fixed-price federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Ampersand Biosciences LLC, a woman-owned small business. The contract is for the development of reagents to support immunologic analysis of non-mammalian and underrepresented mammalian models, such as ferrets and mice, under SBIR Topic 107. This aligns with NIAID's mission to conduct and support research to...
This is a firm fixed-price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), to Ampersand Biosciences LLC, a woman-owned small business. The $599,987 contract is for the development of monoclonal antibodies to chemokines in the ferret model of respiratory disease. The contract is not set aside. Ampersand Biosciences is a biotechnology research company that has received multiple prior NIAID...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Southern Research Institute, a non-profit research organization, for $54,095.00. The contract is for ferret studies and analysis, which are likely related to NIAID's research on emerging infectious diseases. Southern Research Institute has a history of providing drug discovery, preclinical services, and other research and development support to various government...
This is a $356,021 firm-fixed-price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Avantgen Inc., a San Diego-based biotechnology company. The contract is for the development of rabbit monoclonal antibodies for ferret biomarkers. This work is set aside for small businesses. Avantgen has previously received NIH contracts to develop rapid diagnostic...
This federal contract award, valued at $12,571.50, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Triple F Farms, LLC, a for-profit limited liability company based in Gillett, Pennsylvania, on October 17, 2024. The contract is for the delivery of "Influenza-Free Ferrets" and does not have a set-aside designation, indicating it was...
This is a $1,497,384.00 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Avantgen Inc., a small business biotechnology company based in San Diego, California. The contract is for the development of rabbit monoclonal antibodies for use as ferret biomarkers. This contract is not associated with a larger contract vehicle and does not have a set-aside designation. Avantgen Inc. has previously been awarded multiple federal...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Southern Research Institute, a non-profit research organization, for preclinical evaluation of influenza vaccines and vaccine strategies using ferret models. The contract has a ceiling value of $3,291,183.38 and is funded as a cost-plus-fixed-fee arrangement. It was issued under NIAID's Preclinical Models of Infectious Diseases...
This federal contract award, worth $42,917.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Triple F Farms Inc., a for-profit subchapter S corporation. The contract is for the delivery of 144 ferrets, 15-17 weeks old, along with ferret serum samples, packaging, shipping, and air freight. This contract was awarded under the American Recovery and Reinvestment Act (ARRA) and does not utilize any small business set-asides. The ferrets are intended to support...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $27,685 firm fixed price purchase order to Triple F Farms LLC of Gillett, Pennsylvania. The contract is to provide 24 influenza antigen-free ferrets that are 12-15 weeks old and female and spayed, as well as 24 influenza antigen-free ferrets that are 12-15 weeks old, castrated, and de-scented. The ferrets will undergo vaccinations for canine distemper and...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services. The contract was awarded to Triple F Farms Inc., a for-profit subchapter S corporation, to provide 67 ferrets aged 9-23 weeks for a firm fixed price of $22,914.00. The contract has a total ceiling value of $34,014.00 and does not utilize any small business set-asides. The ferrets are likely to be used to support...